Hepion Partners With New Day Diagnostics To Commercialize Diagnostic Tests
7/5 15:38
(RTTNews) - Hepion Pharmaceuticals, Inc. (HEPA), a clinical stage biopharmaceutical company, Wednesday said it has entered into a binding letter of intent (LOI) with New Day Diagnostics LLC, a developer of non-invasive diagnostic tests, to commercialize diagnostic tests for celia...